Case Type: Mergers & Acquisitions

Voyager Acquisition Corp. (NASDAQ: VACH) related to its merger with Veraxa Biotech AG. Upon completion of the proposed transaction, each Voyager Class A and B ordinary share will be cancelled and exchanged for one Class A ordinary share in the combined company

Augusta Gold Corp. (OTCMKTS: AUGG) related to its merger with AngloGold Ashanti Holdings, Inc. Upon completion of the proposed transaction, each outstanding share of Augusta will be converted in the right to receive CAD$1.70 in cash.

Onconetix, Inc. (NASDAQ: ONCO) related to its merger with Ocuvex Therapeutics, Inc. Upon completion of the proposed transaction, each share of Ocuvex will be exchanged for a number of Onconetix shares based on a defined exchange ratio, resulting in Ocuvex shareholders owning approximately 90% of the combined company and Onconetix shareholders owning approximately 10%.

Longevity Health Holdings, Inc. (NASDAQ: XAGE) related to its merger with 20/20 BioLabs, Inc. Upon completion of the proposed transaction, Longevity shareholders are expected to own approximately 49.9% of the combined company.

Waters Corporation (NYSE: WAT) related to its merger with BD and Company’s Biosciences and Diagnostic Solutions. Upon completion of the proposed transaction, existing Waters shareholders are expected to own approximately 60.8% of the combined company.

Cayson Acquisition Corp. (NASDAQ: CAPN) related to its merger with Mango Financial Group Limited. Under the terms of the proposed transaction, each Cayson ordinary share will convert into one Mango Class A ordinary share.

ESSA Pharma Inc. (NASDAQ: EPIX) related to its sale to Xeno Acquisition Corp. Upon completion of the transaction, ESSA shareholders will receive a cash payment per share to be calculated based upon ESSA’s cash balance at closing minus transaction costs, liability and legal exposure review, and a $4 million transaction fee payable to Xeno. Additionally, … Read more

Monogram Technologies Inc. (NASDAQ: MGRM) related to its sale to Zimmer Biomet Holdings, Inc. Under the terms of the proposed transaction, Monogram shareholders would receive an upfront payment of $4.04 per share in cash, and one non-tradeable contingent value right collectively worth up to $12.37 per share in cash payable (i) $1.04 upon completion of … Read more

Signature Bank of Georgia (OTCMKTS: SGBG) related to its merger with First Community Corporation. Upon completion of the proposed transaction, Signature Bank shareholders will receive 0.6410 shares of First Community common stock per Signature Bank share.

First Community Corporation (NASDAQ: FCCO) related to its merger with Signature Bank of Georgia. Upon completion of the proposed transaction, Signature Bank shareholders will receive 0.6410 shares of First Community common stock per Signature Bank share.